Haemonetics (HAE) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Haemonetics Corporation  (NYSE: HAE)


Haemonetics's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HAE Gross Profit Margin (Sep 26 2026)
Q2 		(Jun 27 2026)
Q1 		(Mar 28 2026)
Q4 		(Dec 27 2025)
Q3 		(Sep 27 2025)
Q2
Y / Y Revenue Change 9.49 %
Seq. Revenue Change 5.42 %
Revenue In Millions $357.76
Gross Profit Margin 61.75 %
Gross Profit Margin Total Ranking # 1468
Gross Profit In Millions $220.91
Y / Y Gross Profit Change 13.44 %
Seq. Gross Profit Change 8.93 %


Commenting Second Quarter 2026 Gross Profit Margin
Haemonetics Corporation Gross Profit grew by 8.93 % in Q2 sequentially to 221 millions, while Revenue increased by 5.42 %, this led to improvement in the company's Gross Profit Margin to 61.75 % a new company high.


Observing second quarter 2026 results within Medical Equipment & Supplies industry 103 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1468, from total ranking in the previous quarter at 1498.
Learn about Gross Margin
HAE's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 104
Healthcare Sector # 270
Overall # 1456

Gross Profit Margin Statistics
High Average Low
61.75 % 49.53 % 36 %
(Sep 26 2026)   (Apr 01 2017)


HAE Gross Income Trends • More of HAE's Profitabilty Ratios • HAE Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
HAE's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
HAE's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for HAE's Competitors
Gross Profit Margin Profit Margin for Haemonetics's Suppliers
Gross Profit Margin Profit Margin for HAE's Customers

You may also want to know
HAE's Annual Growth Rates HAE's Profitability Ratios HAE's Asset Turnover Ratio HAE's Dividend Growth
HAE's Roe HAE's Valuation Ratios HAE's Financial Strength Ratios HAE's Gross Profit Growth
HAE's Roa HAE's Inventory Turnover Ratio HAE's Growth Rates HAE's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 26 2026, within Medical Equipment & Supplies Industry Gross Profit MarginSep 26 2026 MRQ Gross ProfitSep 26 2026 MRQ Revenue
Ceribell Inc   89.77 %$ 26.340  Millions$ 29.341  Millions
Delcath Systems Inc   88.84 %$ 31.184  Millions$ 35.102  Millions
Electrocore Inc   88.47 %$ 8.573  Millions$ 9.690  Millions
Cvrx inc   86.74 %$ 11.998  Millions$ 13.832  Millions
Neuraxis Inc   86.60 %$ 1.756  Millions$ 2.028  Millions
Trisalus Life Sciences Inc   86.15 %$ 11.095  Millions$ 12.878  Millions
Inspire Medical Systems inc   86.05 %$ 177.858  Millions$ 206.695  Millions
Sight Sciences Inc   85.94 %$ 21.420  Millions$ 24.923  Millions
Glaukos Corp  85.23 %$ 179.866  Millions$ 211.030  Millions
Avita Medical Inc   84.02 %$ 21.941  Millions$ 26.114  Millions
Mobia Medical Inc   83.25 %$ 13.000  Millions$ 15.616  Millions
Electromed Inc   79.95 %$ 14.937  Millions$ 18.682  Millions
Mimedx Group Inc   79.80 %$ 49.702  Millions$ 62.283  Millions
Treace Medical Concepts Inc   79.48 %$ 38.350  Millions$ 48.253  Millions
Si bone inc   79.29 %$ 44.167  Millions$ 55.704  Millions
Edwards Lifesciences Corporation  78.48 %$ 1,346.300  Millions$ 1,715.500  Millions
Profound Medical Corp   78.13 %$ 7.680  Millions$ 9.830  Millions
Carlsmed Inc   77.32 %$ 16.665  Millions$ 21.554  Millions
Atricure Inc   77.27 %$ 119.350  Millions$ 154.450  Millions
Sanuwave Health Inc   77.27 %$ 6.629  Millions$ 8.579  Millions
Novocure Limited  76.98 %$ 148.870  Millions$ 193.399  Millions
Tactile Systems Technology Inc   76.74 %$ 70.489  Millions$ 91.858  Millions
Iradimed Corporation  76.26 %$ 18.456  Millions$ 24.203  Millions
Pulmonx Corporation  76.19 %$ 17.399  Millions$ 22.835  Millions
Omada Health Inc   75.88 %$ 69.282  Millions$ 91.306  Millions
Anteris Technologies Global Corp   75.72 %$ 0.393  Millions$ 0.519  Millions
Insulet Corporation  75.07 %$ 632.100  Millions$ 842.000  Millions
Axogen inc   74.81 %$ 56.731  Millions$ 75.834  Millions
Orthopediatrics Corp  74.28 %$ 53.976  Millions$ 72.661  Millions
Irhythm Holdings Inc   74.23 %$ 164.494  Millions$ 221.592  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.